Serum leptin and myocardial infarction in hypertension

Susanna M Wallerstedt1, Anna-Lena Eriksson, Anders Niklason

  • 1Department of Clinical Pharmacology, Sahlgrenska University Hospital, Sahlgrenska, Göteborg, Sweden. susanna.wallerstedt@pharm.gu.se

Blood Pressure
|December 8, 2004
PubMed

Insights

Serum leptin, a hormone from fat tissue, predicts myocardial infarction (MI) risk in hypertensive individuals. Higher leptin levels are linked to MI, especially in women, independent of other risk factors.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Syndrome

Background:

  • Leptin, a hormone secreted by adipose tissue, plays a role in cardiovascular regulation.
  • Hypertension is a significant risk factor for cardiovascular diseases, including myocardial infarction (MI).

Purpose of the Study:

  • To investigate the potential of serum leptin levels to predict the risk of myocardial infarction (MI) in a cohort of hypertensive men and women.
  • To determine if the association between leptin and MI is independent of established cardiovascular risk factors.

Main Methods:

  • Prospective study design.
  • Comparison of serum leptin concentrations between 171 hypertensive patients who experienced MI and 342 matched hypertensive controls.
  • Statistical analysis to assess the association between leptin and MI, adjusting for traditional risk factors.

Main Results:

  • Mean serum leptin concentration was significantly higher in MI patients (25.1 ng/ml) compared to controls (20.0 ng/ml) (p = 0.007).
  • The association between serum leptin and MI remained significant and independent of traditional cardiovascular risk factors.
  • Leptin concentrations were higher in women than in men, and in women, serum leptin emerged as the most potent predictor of MI.

Conclusions:

  • Serum leptin is significantly associated with an increased risk of myocardial infarction in hypertensive individuals.
  • Leptin levels may serve as a valuable biomarker for estimating MI risk, particularly in hypertensive women.
  • These findings highlight the potential clinical utility of leptin in cardiovascular risk stratification.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...